There is some controversial evidence regarding the beneficial and pathogenic effects of IFN-γ in development and therapy of autoimmune and inflammatory diseases, such as systemic Lupus erythematodes, multiple sclerosis, rheumatoid arthritis, and arteriosclerosis [34,37,38]. This evidence concerns the gene IFNG and arteriosclerosis disorder.